Cannonau Corp. CNNC OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

70/100

2/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Cannonau Corp. (CNNC) reported total assets of $0.00 and total liabilities of $0.00 for fiscal year 2023, resulting in total equity of $0.00.

The company held $0.00 in cash and short-term investments. Total debt stood at $0.00.

Criteria supported by this page:

HEALTH (83/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
MOAT (50/100) — Total assets $0.00 and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 66/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

70/100

SG Score

View full scorecard →

✓

VALUE

100/100

Price-to-Earnings & upside

→ Valuation

—

FUTURE

N/A

No coverage

✗

PAST

25/100

→ Income

✗

HEALTH

83/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

50/100

→ Income

✓

GROWTH

90/100

→ Income

—

INCOME

N/A

No coverage

Cannonau Corp. Balance Sheet History

Metric	FY2023	FY2022	FY2021	FY2020
Total Assets	$0.00	$9.03K	$8.76K	$19.34K
Total Liabilities	$0.00	$347.26K	$261.04K	$168.16K
Total Debt	$0.00	$0.00	$242.36K	$150.83K
Cash & Investments	$0.00	$157.00	$143.00	$164.00
Total Stockholders Equity	$0.00	$-338.24K	$-252.29K	$-148.82K